Paul Bus

572 total citations
9 papers, 302 citations indexed

About

Paul Bus is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Epidemiology. According to data from OpenAlex, Paul Bus has authored 9 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 4 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in Paul Bus's work include Acute Lymphoblastic Leukemia research (8 papers), Pregnancy and Medication Impact (4 papers) and Inflammatory Bowel Disease (4 papers). Paul Bus is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Pregnancy and Medication Impact (4 papers) and Inflammatory Bowel Disease (4 papers). Paul Bus collaborates with scholars based in Netherlands and United States. Paul Bus's co-authors include L.G.J.B. Engels, L.P. Bos, Lennard P. L. Gilissen, Luc J. J. Derijks, P. M. Hooymans, Daniël W. Hommes, Sander J. H. van Deventer, Wouter L. Curvers, Dennis R. Wong and P. M. Hooymans and has published in prestigious journals such as British Journal of Clinical Pharmacology, Journal of Crohn s and Colitis and European Journal of Gastroenterology & Hepatology.

In The Last Decade

Paul Bus

8 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Bus Netherlands	7	225	140	73	46	44	9	302
Jusuf Zlatanic United States	7	160 0.7×	149 1.1×	95 1.3×	36 0.8×	14 0.3×	10	407
Takahiro Beppu Japan	11	83 0.4×	189 1.4×	113 1.5×	11 0.2×	19 0.4×	18	443
Jacqueline Jossen United States	10	43 0.2×	263 1.9×	204 2.8×	49 1.1×	46 1.0×	13	358
Marie Balsat France	11	121 0.5×	33 0.2×	35 0.5×	171 3.7×	46 1.0×	41	332
Maja Bulatović Ćalasan Netherlands	11	167 0.7×	33 0.2×	21 0.3×	243 5.3×	41 0.9×	18	424
Phillip Minar United States	12	44 0.2×	317 2.3×	207 2.8×	23 0.5×	70 1.6×	40	434
Justin Côté-Daigneault Canada	9	23 0.1×	132 0.9×	141 1.9×	13 0.3×	11 0.3×	17	311
Édouard Chabrun France	12	37 0.2×	198 1.4×	204 2.8×	15 0.3×	6 0.1×	25	453
Inmaculada Calvo Penadés Spain	7	25 0.1×	36 0.3×	51 0.7×	85 1.8×	13 0.3×	23	208
Ulrik Malthe Overgaard Denmark	9	104 0.5×	12 0.1×	84 1.2×	133 2.9×	51 1.2×	33	309

Countries citing papers authored by Paul Bus

Since Specialization

Citations

This map shows the geographic impact of Paul Bus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bus more than expected).

Fields of papers citing papers by Paul Bus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Bus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bus. The network helps show where Paul Bus may publish in the future.

Co-authorship network of co-authors of Paul Bus

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Bus. A scholar is included among the top collaborators of Paul Bus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Bus. Paul Bus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Winkens, Björn, Paul Bus, Marieke Pierik, et al.. (2024). Early therapeutic drug monitoring helps to identify inflammatory bowel disease patients with a high risk to fail thiopurine treatment. British Journal of Clinical Pharmacology. 90(12). 3296–3307.

Winkens, Björn, Paul Bus, Marieke Pierik, et al.. (2022). Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients. Therapeutic Drug Monitoring. 44(6). 747–754. 3 indexed citations

Wong, Dennis R., Marieke Pierik, Margien L. Seinen, et al.. (2013). The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Journal of Crohn s and Colitis. 8(2). 120–128. 16 indexed citations

Gilissen, Lennard P. L., Dennis R. Wong, L.G.J.B. Engels, et al.. (2012). Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Journal of Crohn s and Colitis. 6(6). 698–707. 56 indexed citations

Derijks, Luc J. J., Lennard P. L. Gilissen, L.G.J.B. Engels, et al.. (2006). Pharmacokinetics of 6-Thioguanine in Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 28(1). 45–50. 47 indexed citations

Derijks, Luc J. J., et al.. (2004). Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology. 16(7). 705–710. 18 indexed citations

Gilissen, Lennard P. L., Luc J. J. Derijks, L.P. Bos, et al.. (2004). Therapeutic Drug Monitoring in???Patients with Inflammatory Bowel???Disease and Established Azathioprine Therapy. Clinical Drug Investigation. 24(8). 479–486. 26 indexed citations

Derijks, Luc J. J., Lennard P. L. Gilissen, L.G.J.B. Engels, et al.. (2004). Pharmacokinetics of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 26(3). 311–318. 103 indexed citations

Bus, Paul, Hein W. Verspaget, J. Han van Krieken, et al.. (1999). Treatment of mesenteric desmoid tumours with the anti-oestrogen ic agent toremifene. European Journal of Gastroenterology & Hepatology. 11(10). 1179–1184. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact